节点文献
膜材料在抗癌药物奥沙利铂制备中的银控制
The Silver Control of Anti-cancer Drugs Oxaliplatin Preparation with Membrane Materials
【摘要】 为了控制奥沙利铂生产中的银离子,采用微孔滤膜过滤,5批实验显示在奥沙利铂的制备中,银离子都小于5×10-6μm/g,达到欧洲药典(EP4)标准,说明采用微孔滤膜过滤法可以有效控制银离子浓度生产出合格的产品,并取得好的效果。
【Abstract】 In order to control the silver ions of oxaliplatin production,using microfiltration membrane filtration,5 batch experiments showed that silver ions in the oxaliplatin preparation were less than 5×10-6μm/g,and reached European Pharmacopoeia(EP4) standard.It indicated that using microfiltration membrane filtration method can effectively control of silver ion concentration,produce qualified products,and achieve good effect.
【基金】 昆明市科技型中小企业技术创新基金项目(CJ2005016)
- 【文献出处】 广州化工 ,Guangzhou Chemical Industry , 编辑部邮箱 ,2010年12期
- 【分类号】TQ462
- 【下载频次】51